Microscopic examination of fetal placenta exposed to <i>U.simensis</i> essential oil: D-decidua, DA-decidual artery, DV-decidual vein, blue arrow head-maternal blood space, CBV-cho... by Bickes Wube (21678222)

Subjects:

External examination of 20-day old rat fetuses treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Histopathological scoring of fetal placenta exposed to <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Chemical compositions of <i>U.simensis</i> essential oil identified through GC-MS analysis. by Bickes Wube (21678222)

Subjects:

Axial and extremity bone ossification centers of rat fetuses treated with <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Fetal outcomes of gravid rats treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Fetal growth, anogenital distance and placental weight of rat fetuses treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Developmental scores of cardiovascular and musculoskeletal systems of rat embryos treated with <i>U.simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Dietary intake and weight gain of pregnant dams treated with <i>U. simensis</i> essential oil. by Bickes Wube (21678222)

Subjects:

Implantation and resorption of 20-day old rat fetuses treated with <i>U.simensis</i> essential oil I-implantation, R-resorption, TR-total resorption only in one gravid rat, O-ovary... by Bickes Wube (21678222)

Subjects:

In vivo development of 12-day old rat embryos treated with <i>U.simensis</i> essential oil: VV – vitelline blood vessels, YS-yolk sac, TE- telencephalon, ME-mesencephalon, PA-phary... by Bickes Wube (21678222)

Subjects:

Skeletal ossification of alizarin red stained 20-day old rat fetuses treated with <i>U.simensis</i> essential oil: TL-thoracic and lumbar vertebrae, O-occipital bone, MC-metacarpal... by Bickes Wube (21678222)

Subjects:

All raw data support findings of the study. by Bickes Wube (21678222)

Subjects:

A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

“…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [⁶⁸Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”

A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

“…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [⁶⁸Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”

Annual incidence of insomnia disorder (ICD-CODE: G47) Bar: rate of insomnia disorder relative to all patients; Line: average number of outpatient visits for patients with insomnia... by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Distribution of non-pharmacological treatment related to insomnia disorder (2002–2019). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Detailed treatment status of patients who did not receive non-pharmacological treatment at first diagnosis but received it later. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

Mean interval from initial diagnosis to initiation of non-pharmacological treatment by year. by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”

General information of patient who diagnosis insomnia disorder (N = 518,119). by Mingee Choi (15250732)

Subjects: “…treatment initiation decreased…”